Role of Cyclooxygenase-2 expression as a prediction of persistent cervical low grade squamous intraepithelial lesion

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

TCTR

Registry ID

TCTR20191030003

Enrollment

175

Registered

2019-10-30

Start date

2019-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Women age 21&#45

Interventions

patients who have result of cervical tissue biopsy are CIN1 after follow up to 12 month or more than 12 month,patients who have result of cervical tissue biopsy are Normal cervical tissue or HPV effec

Screening,Screening

Persistent group,Regression group

Eligibility

Sex/Gender

Female

Age

21 Years to 65 Years

Inclusion criteria

Inclusion criteria: Women age 21-65 year with histological diagnosis of CIN 1 who attending colposcopic clinic at chulalongkorn hospital PAP and cervical tissue biopsy were examined and determined by pathologists in chulalongkorn hospital

Exclusion criteria

Exclusion criteria: History of cervical cancer Previous hysterectomy Previous radiation Prior CIN 1 diagnosis or treatment with laser ablation or cryotherapy within 12 month Incomplete data record

Design outcomes

Primary

Measure	Time frame
Score of COX-2 expression after pathologic report improved Allred score	—

Secondary

Measure	Time frame
age, parity, partner, first SI, previous treatment, previous PAP result, education, income, after pathologic report improved Interview and record form	—

Countries

Thailand

Contacts

Public ContactDr. Pitchaya Homsup

Faculty of Medicine, Research affairs Chulalongkorn University

pitchaya_66@hotmail.com0840894057

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Role of Cyclooxygenase&#45;2 expression as a prediction of persistent cervical low grade squamous intraepithelial lesion